Press Release 08 Mar 2016

Tuesday, 8th March, 2016 - IDA Ireland, the Irish Government’s foreign investment agency, today welcomed news that Grifols is to invest an additional $85m in its biologics plant at Grangecastle, Co Dublin.

The agency said the latest Grifols invesment will add to the growing biologics manufacturing cluster in Ireland, which is the fastest growing subsector in pharmaceutical industry.

Grifols said it was bringing forward plans for the construction of a purification plant for the protein albumin to cater for rising demand. Construction will begin towards the end of this year, with the plant expected to be operation-ready in early 2020.

Martin Shanahan, Chief Executive of IDA Ireland said the biologics sector had grown to over 6,000 people in Ireland in the last 10 years and accounted for over €10bn of investment, creating significant secondary employment in construction and other services.

Grifols only opened its plant at Grange Castle last year and already we can see how it is contributing to the company’s global operations.  Ireland is rapidly developing an internationally recognised hub for biologics and Grifols’ latest investment will strengthen this further.

Martin Shanahan, CEO, IDA Ireland

"Grifols only opened its plant at Grange Castle last year and already we can see how it is contributing to the company’s global operations.  Ireland is rapidly developing an internationally recognised hub for biologics and Grifols’ latest investment will strengthen this further’’.

Contact us

Contact IDA Ireland

You'll find us responsive to your needs, proactive, professional and willing to go the extra mile.

Contact IDA Ireland

International Offices

We have 28 Offices worldwide helping support companies expand their operations in Ireland.

Find your nearest office